Residual Gastric Area & Weight Loss After Sleeve Gastrectomy

Status Completed

Clinical Trial Summary

BACKGROUND: The aim of this study is to evaluate the impact of the actual size and area of the remnant stomach, as measured by Upper gastrointestinal tract radiography, on weight loss after LSG. MATERIALS AND METHODS: From May 2017 to December 2019, 56 patients with morbid obesity were admitted to the Department of Medical and Surgical Sciences, University of Foggia and underwent laparoscopic sleeve gastrectomy. UGI tract radiography was performed on day two after the operation to rule out leakage.

Clinical Trial Description

Study design and setting From May 2017 to December 2019, 56 patients with morbid obesity were admitted to the Department of Medical and Surgical Sciences, University of Foggia and underwent laparoscopic sleeve gastrectomy. UGI tract radiography with water-soluble contrast medium was performed on the second day after the operation to rule out leakage. The radiographic images were collected through a software program called "PACS" which combined with a viewer for image processing, allows for the calculation of the residual stomach area (RSA). RSA was correlated with postoperative weight (EWL) at 1, 6, and 12 months. Eligibility criteria Adult patients of both genders with morbid obesity defined as BMI>40 kg/m2 or BMI>35 kg/m2 with at least one associated major comorbidity were included. We excluded patients with secondary obesity due to endocrine and psychological disorders, patients with previous bariatric procedures and patients unwilling to comply with postoperative diet and exercise program. Statistical analysis Continuous data were expressed as mean and standard deviation (SD) and they were analyzed using Student's T test. The correlation between gastric volume before and after LSG and BMI and weight loss was measured using Pearson correlation coefficient test. Correlation coefficients were classified as strong (-1.0 to -0.5 or 0.5 to 1.0), moderate (-0.5 to -0.3 or 0.3 to 0.5), and weak (-0.3 to -0.1 or 0.1 to 0.3). P<0.05 was considered statistically significant. This work is fully compliant with the STROCSS criteria ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05151107
Study type	Observational
Source	University of Foggia
Contact
Status	Completed
Phase
Start date	July 1, 2017
Completion date	July 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04517591` - Reducing Sedentary Time in Bariatric: The Take a STAND for Health Study	N/A
Active, not recruiting	`NCT04583683` - Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities	N/A
Completed	`NCT01550601` - Impact of the Preservation of the Gastric Antrum in the Technique of Sleeve Gastrectomy for the Treatment of the Morbid Obesity	N/A
Completed	`NCT03638843` - Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2	N/A
Recruiting	`NCT05917795` - Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates	N/A
Completed	`NCT03339791` - Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial	N/A
Recruiting	`NCT05711758` - Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Not yet recruiting	`NCT04209842` - Effectiveness Gastric Balloon in Obese Adolescents	N/A
Recruiting	`NCT03100292` - Korean OBEsity Surgical Treatment Study	N/A
Active, not recruiting	`NCT04357119` - Common Limb Length in One-anastomosis Gastric Bypass	N/A
Completed	`NCT03210207` - Gastric Plication in Mexican Patients	N/A
Completed	`NCT02590406` - EPO2-A: Evaluation of Pre-Oxygenation in Morbid Obesity: Effect of Position and Positive Pressure Ventilation	N/A
Completed	`NCT01840020` - BAR-trial: Bioavailability of Ethanol Following Bariatric Surgery
Completed	`NCT01183975` - Swedish Adjustable Gastric Banding Observational Cohort Study	N/A
Completed	`NCT03872024` - Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients	N/A
Terminated	`NCT05993169` - Body Composition Optimization Intervention RCT	N/A
Not yet recruiting	`NCT05974995` - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer	N/A
Recruiting	`NCT05554016` - The UFO (Ultra Processed Foods in Obesity) Project
Not yet recruiting	`NCT05499949` - The Franciscus Obesity NASH Study
Completed	`NCT05519423` - Investigation of the Effectiveness of Whatsapp-Based Physical Activity Incentive Program in Morbidly Obese Individuals	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Residual Gastric Area and Weight Loss After Sleeve Gastrectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms